BR112015001018A2 - uso de um creme que protege contra os efeitos de agentes químicos agressivos em contato com a pele - Google Patents

uso de um creme que protege contra os efeitos de agentes químicos agressivos em contato com a pele

Info

Publication number
BR112015001018A2
BR112015001018A2 BR112015001018A BR112015001018A BR112015001018A2 BR 112015001018 A2 BR112015001018 A2 BR 112015001018A2 BR 112015001018 A BR112015001018 A BR 112015001018A BR 112015001018 A BR112015001018 A BR 112015001018A BR 112015001018 A2 BR112015001018 A2 BR 112015001018A2
Authority
BR
Brazil
Prior art keywords
cream
effects
representing
protects against
skin contact
Prior art date
Application number
BR112015001018A
Other languages
English (en)
Other versions
BR112015001018B1 (pt
Inventor
Blomet Joël
Mathieu Laurence
Meyer Marie-Claude
Original Assignee
Prevor Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevor Int filed Critical Prevor Int
Publication of BR112015001018A2 publication Critical patent/BR112015001018A2/pt
Publication of BR112015001018B1 publication Critical patent/BR112015001018B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51Chelating agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

resumo de patente de invenção para: “uso de um creme que protege contra os efeitos de agentes químicos agressivos em contato com a pele”. a presente invenção se refere à utilização de uma emulsão para a proteção da pele contra os agentes químicos agressivos, em que esta emulsão compreende pelo menos um agente quelante anfotérico que compreende um complexo baseado em alumínio e em ácido etilenodiaminotetracético ou o sal trissódico do mesmo, tendo a fórmula geral [al (y) bn]c'dc com b representando oh-, bo2-, h+, y representando um tetracarboxilato que pode ser protonado quatro vezes para formar o ácido etilenodiaminotetracético, n representando um número inteiro igual a 0, 1, 2 ou 3, d é um contra-íon, de preferência, na+, c sendo um inteiro igual a 0, 1, 2 ou 3 e c' sendo um número relativo tendo o mesmo valor absoluto como c.
BR112015001018-0A 2012-07-18 2013-07-17 Uso de um creme que protege contra os efeitos de agentes químicos agressivos em contato com a pele BR112015001018B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1256939 2012-07-18
FR1256939A FR2993466B1 (fr) 2012-07-18 2012-07-18 Utilisation d'une creme de protection contre les effets des agents chimiques agressifs en contact avec la peau
PCT/FR2013/051717 WO2014013194A1 (fr) 2012-07-18 2013-07-17 Utilisation d'une creme de protection contre les effets des agents chimiques agressifs en contact avec la peau

Publications (2)

Publication Number Publication Date
BR112015001018A2 true BR112015001018A2 (pt) 2017-06-27
BR112015001018B1 BR112015001018B1 (pt) 2021-09-08

Family

ID=47137836

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112015001018-0A BR112015001018B1 (pt) 2012-07-18 2013-07-17 Uso de um creme que protege contra os efeitos de agentes químicos agressivos em contato com a pele
BR112015001019-9A BR112015001019B1 (pt) 2012-07-18 2013-07-17 Uso de um agente quelante anfotérico para prevenir alergias de contato

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR112015001019-9A BR112015001019B1 (pt) 2012-07-18 2013-07-17 Uso de um agente quelante anfotérico para prevenir alergias de contato

Country Status (18)

Country Link
US (3) US10953024B2 (pt)
EP (2) EP2874604B1 (pt)
CN (4) CN104507501A (pt)
AU (2) AU2013291792B2 (pt)
BR (2) BR112015001018B1 (pt)
CA (2) CA2878650C (pt)
DK (2) DK2874661T3 (pt)
ES (2) ES2690060T3 (pt)
FR (1) FR2993466B1 (pt)
IN (1) IN2014DN10924A (pt)
MX (2) MX356811B (pt)
NO (1) NO2874604T3 (pt)
NZ (2) NZ703258A (pt)
PL (2) PL2874661T3 (pt)
PT (1) PT2874604T (pt)
SI (1) SI2874661T1 (pt)
TR (1) TR201815143T4 (pt)
WO (2) WO2014013194A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3093001B1 (fr) * 2019-02-22 2022-06-10 Prevor Int Composition pour enlever des residus chimiques et ses utilisations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2604900B1 (fr) * 1986-10-08 1989-01-13 Blomet Marie Claude Solution physiologique pour le lavage des parties du corps humain ayant ete mises en contact avec un acide fluorhydrique et concentre pour sa preparation
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US5587400A (en) * 1993-04-19 1996-12-24 Marie-Claude Blomet epouse Meyer Physiological composition for the treatment of thermal or chemical burns
US5665804A (en) * 1996-02-05 1997-09-09 Dow Corning Corporation Silicone latex solvent thickening
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
US6242042B1 (en) * 1998-09-14 2001-06-05 Lrc Products Ltd. Aqueous coating composition and method
US6582683B2 (en) * 2000-01-04 2003-06-24 Skinvisible Pharmaceuticals, Inc. Dermal barrier composition
FR2809959B1 (fr) * 2000-06-07 2004-10-29 Marie Claude Meyer Utilisation d'un complexe d'aluminium et de ligand ethylenediamine-tetraacetique pour la prevention et/ou le traitement des urticaires
GB0403702D0 (en) * 2004-02-19 2004-03-24 Boots Co Plc Skincare compositions
WO2005040114A1 (en) * 2003-10-14 2005-05-06 Oxagen Limited Compounds having crth2 antagonist activity
GB0324084D0 (en) * 2003-10-14 2003-11-19 Oxagen Ltd Compounds
US20090019224A1 (en) * 2005-02-02 2009-01-15 Pocrass Alan L Data Storage and Transfer Device and Method
ES2720332T3 (es) * 2008-01-18 2019-07-19 Vystar Corp Látex de caucho natural con alergenicidad reducida y método de fabricación
WO2011041680A2 (en) * 2009-10-02 2011-04-07 The Brigham And Women's Hospital, Inc. Compositions and methods of prophylaxis for contact dermatitis

Also Published As

Publication number Publication date
FR2993466A1 (fr) 2014-01-24
CN104470501A (zh) 2015-03-25
EP2874604B1 (fr) 2018-02-14
AU2013291792B2 (en) 2017-11-09
EP2874604A1 (fr) 2015-05-27
PT2874604T (pt) 2018-05-11
CN104507501A (zh) 2015-04-08
WO2014013194A1 (fr) 2014-01-23
MX356811B (es) 2018-06-13
CN108606964A (zh) 2018-10-02
DK2874604T3 (en) 2018-05-22
NZ703409A (en) 2016-11-25
BR112015001019B1 (pt) 2022-07-19
TR201815143T4 (tr) 2018-11-21
CA2878882A1 (fr) 2014-01-23
BR112015001018B1 (pt) 2021-09-08
EP2874661A1 (fr) 2015-05-27
MX2015000786A (es) 2015-09-16
EP2874661B1 (fr) 2018-08-08
AU2013291793B2 (en) 2017-11-23
CA2878650C (fr) 2020-07-21
FR2993466B1 (fr) 2014-08-15
BR112015001019A2 (pt) 2017-06-27
PL2874661T3 (pl) 2018-12-31
US20210275553A1 (en) 2021-09-09
NO2874604T3 (pt) 2018-07-14
ES2690060T3 (es) 2018-11-19
CA2878882C (fr) 2020-08-18
US10953024B2 (en) 2021-03-23
SI2874661T1 (sl) 2018-11-30
WO2014013195A1 (fr) 2014-01-23
US20150190357A1 (en) 2015-07-09
MX2015000785A (es) 2015-09-16
NZ703258A (en) 2016-11-25
PL2874604T3 (pl) 2018-07-31
IN2014DN10924A (pt) 2015-09-18
US11197874B2 (en) 2021-12-14
CN110179686A (zh) 2019-08-30
AU2013291793A1 (en) 2015-01-22
MX359747B (es) 2018-10-08
DK2874661T3 (en) 2018-11-05
ES2667709T3 (es) 2018-05-14
CA2878650A1 (fr) 2014-01-23
AU2013291792A1 (en) 2015-01-22
US20150202217A1 (en) 2015-07-23

Similar Documents

Publication Publication Date Title
BR112015014477A2 (pt) composições para limpeza pessoal contendo aminoácido de zinco/haleto de trimetilglicina
EA201290990A1 (ru) Индивидуальное моющее очищающее средство с мягкодействующими поверхностно-активными системами, содержащими определенные алканоиловые химические соединения и определенный поверхностно-активный продукт на основе жирного ацилизетионата и при необходимости агент, благотворно влияющий на кожу или волосы
BR112015009806A2 (pt) composições adjuvantes aquosas
BR112015007546A2 (pt) composições de ácido percarboxílico estáveis e usos das mesmas
BR112013022495A2 (pt) formulação farmacêutica aquosa de tapentadol para administração oral
BRPI0913063A8 (pt) Uso de um composto acilaminoácido ou um sal do mesmo para gerar uma sensação principalmente picante e não ardente em uma preparação alimentícia, e preparação alimentícia compreendendo o referido composto
BR112015021456A2 (pt) uso tópico de uma formulação antimicrobiana
BR112014001802A2 (pt) fluido de manutenção de poço e método de manutenção de poço com fluido
BR112013020767A2 (pt) composições compreendendo ácido peróxi alfa-cetocarboxílico e métodos para a produção e o uso do mesmo
SV2009003335A (es) Formulaciones para el cancer
BR112012009487A2 (pt) formulações de espessante estáveis
AR071123A1 (es) Composiciones para duchas y banos de inmersion
BR112014005810A2 (pt) formas sólidas de um inibidor da dissociação de transtirretina
BR112014004651A2 (pt) composto de pirazol e uso farmacêutico do mesmo
BR112015026840A2 (pt) composto, sal farmaceuticamente aceitável, composição farmacêutica, uso de um composto, e, método prevenir ou tratar hiperfosfatemia
BR112014011781A2 (pt) agente oleoso de usinagem solúvel em água, fluido de usinagem e método de usinagem
BR112015009989A2 (pt) estabilizante para a hialuronidase e formulação líquida que compreende hialuronidase
WO2012154122A3 (en) A topical formulation for treatment of hyperkeratotic skin
CY1117273T1 (el) Υγρη φαρμακευτικη συνθεση η οποια περιεχει νιτισινονη
BR112013021154A2 (pt) composição de dentifrício
BR112013019394A2 (pt) uso de um agente
BR102013026830B8 (pt) composição de microemulsão e um agente de tratamento de fibra
BR112014028180A2 (pt) emulsão, suplemento dietético, e, uso de uma emulsão
BR112015001018A2 (pt) uso de um creme que protege contra os efeitos de agentes químicos agressivos em contato com a pele
BR112016006522A2 (pt) composição microbicida compreendendo fenoxietanol

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/07/2013, OBSERVADAS AS CONDICOES LEGAIS.